Literature DB >> 23535315

Stage IE/IIE extranodal NK/T-cell lymphoma arising in the nasal cavity: analysis of CT findings and their prognostic value.

J Y Kim1, S-W Lee, J H Lee, C Suh, D H Yoon, B-J Lee, J Huh, E K Choi, J H Kim, S Y Song, S M Yoon, Y S Kim, S S Kim, J-H Park, H S Shin, S-K Chang, S D Ahn.   

Abstract

AIM: To investigate the computed tomography (CT) findings in patients with stage IE/IIE extranodal natural killer/T-cell lymphoma (ENKTL) arising in the nasal cavity and to evaluate whether imaging findings revealed by CT have prognostic value.
MATERIALS AND METHODS: The CT findings of 62 patients diagnosed with IE/IIE ENKTL arising in the nasal cavity were retrospectively reviewed. Imaging findings were investigated, and evaluated imaging findings were analysed for the prognostic value of overall survival (OS) and disease-free survival (DFS).
RESULTS: Of the 62 patients, 21 (34%) presented with a superficial infiltrative, 38 (61%) with a mass forming, and three (5%) with a combined pattern. Of all imaging findings, local invasiveness (n = 26, 42%), including bony destruction, erosion, or soft-tissue involvement, was the only independent prognostic factor for OS [p = 0.008; hazard ratio (HR): 3.85; 95% confidence intervals (CI): 1.42-10.44] and DFS (p = 0.001; HR: 4.25; 95% CI: 1.72-10.47). In a subgroup analysis of 36 cases with no local invasiveness, a superficial infiltrative pattern in one nasal cavity was a positive prognostic factor for OS (p = 0.028) and DFS (p = 0.008).
CONCLUSION: Imaging findings at CT provided clinically useful predictions for treatment outcomes. Local invasiveness revealed by CT findings was a strong prognostic factor for poor OS and DFS. In addition, in patients with no local invasiveness, a superficial infiltrative pattern in one nasal cavity predicted favourable OS and DFS.
Copyright © 2013 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23535315     DOI: 10.1016/j.crad.2012.11.023

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  5 in total

1.  [Efficacy of GLIDE chemotherapy for patients with newly diagnosed advanced-stage or relapsed/refractory extranodal natural killer cell lymphoma].

Authors:  J Ji; B Xiang; Z G Liu; Y Q Jia; H L Zhu; T Niu; L Pan; H Chang; J Huang; Y Wu; J J Li; C He; H B Ma; Y Tang; T Dong; T Liu
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2016-09-14

2.  Extranodal NK/T-cell lymphoma in adolescents: imaging findings of a consecutive 7-year case series.

Authors:  Pujun Guan; Zihang Chen; Lei Chu; Li Zhen; Li Zhang; Ling Pan; Weiping Liu; Rongbo Liu
Journal:  J Int Med Res       Date:  2019-02-06       Impact factor: 1.671

3.  Nomograms based on SUVmax of 18F-FDG PET/CT and clinical parameters for predicting progression-free and overall survival in patients with newly diagnosed extranodal natural killer/T-cell lymphoma.

Authors:  Hongyan Li; Guozhu Shao; Yajing Zhang; Xiaomin Chen; Chengcheng Du; Kun Wang; Zairong Gao
Journal:  Cancer Imaging       Date:  2021-01-08       Impact factor: 3.909

4.  Hemoglobin level, a prognostic factor for nasal extranodal natural killer/T-cell lymphoma patients from stage I to IV: A validated prognostic nomogram.

Authors:  Jianzhong Cao; Shengmin Lan; Liuhai Shen; Hongwei Si; Huan Xiao; Qiang Yuan; Xue Li; Hongwei Li; Ruyuan Guo
Journal:  Sci Rep       Date:  2017-09-08       Impact factor: 4.379

5.  A Multicenter Retrospective Comparison of Sequential versus Sandwich Chemoradiotherapy for Stage IE-IIE Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type.

Authors:  Jin Li; Yajun Li; Meizuo Zhong; Wei Liu; Xianling Liu; Jiwei Li; Kunlun Li; Pingyong Yi
Journal:  J Cancer       Date:  2018-04-12       Impact factor: 4.207

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.